Annual excess costs for type 2 diabetes were estimated to be €499.49 for patients with type 2 diabetes and no antihyperglycemic treatment and range up to €5724.91 for insulin treated patients with type 2 diabetes [64] (Table 1, Fig. 2). The gene discussed is INS; the disease is type 2 diabetes mellitus.